The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular panel sequencing of pre-treatment samples to reveal mechanisms of innate resistance to 3rd generation EGFR TKI treatment in T790M-positive NSCLC patients.
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Carina Heydt
No Relationships to Disclose
 
Barbara Deschler-Baier
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Vanessa Ruesseler
No Relationships to Disclose
 
Jan Stratmann
Honoraria - Novartis
Consulting or Advisory Role - Novartis
 
Susanne Steinhauser
No Relationships to Disclose
 
Rieke Nila Fischer
Honoraria - Bristol-Myers Squibb; MSD Oncology; Roche
Consulting or Advisory Role - Bristol-Myers Squibb
 
Matthias Scheffler
Honoraria - Boehringer Ingelheim; Novartis
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Novartis
 
Jana Fassunke
No Relationships to Disclose
 
Lucia Nogova
Honoraria - Celgene; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer
 
Vanessa Brandes
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Novartis
 
Anna Kostenko
No Relationships to Disclose
 
Frank Griesinger
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Lilly; Novartis; Pfizer
Research Funding - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche
 
Oliver Gautschi
No Relationships to Disclose
 
Martin Sebastian
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb
 
Martin Hellmich
No Relationships to Disclose
 
Lukas C. Heukamp
Employment - NEO New Oncology
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche Pharma AG
 
Sabine Merkelbach-Bruse
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - Novartis; Novartis; Roche
 
Reinhard Buettner
No Relationships to Disclose
 
Juergen Wolf
Honoraria - AstraZeneca; Clovis Oncology; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Novartis
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis